[an error occurred while processing this directive]
|CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER|
U-M named Blue Distinction Center for Complex and Rare CancersPlease Note: The articles listed in the Cancer Center's News Archive are here for historical purposes. The information and links may no longer be up-to-date.
Ann Arbor - The University of Michigan Comprehensive Cancer Center was named a Blue Distinction Center for Complex and Rare Cancers as part of a national program by the Blue Cross and Blue Shield Association.
Blue Distinction Centers for Complex and Rare Cancers are medical facilities that contract with local Blue Cross Blue Shield plans and offer comprehensive inpatient cancer care programs for adults, delivered by multidisciplinary teams with subspecialty training and distinguished clinical expertise in treating complex and rare subtypes of cancer.
The designation covers 11 cancer types:
"The Blue Distinction designation affirms the University of Michigan's leading role in caring for the most complex cancer patients. Our 14 multidisciplinary cancer care clinics provide specialized expertise to patients who come here for initial care of unusual or complex cancers. This program recognizes that," says Douglas Blayney, M.D., medical director at the U-M Comprehensive Cancer Center.
Complex and rare cancers comprise approximately 15 percent of new cancer cases each year, making it challenging for patients to locate or research facilities with oncologists or surgical teams that are experienced in treating these specific malignancies.
"This program is part of our ongoing efforts to raise the overall quality of health care and to collaborate with leading hospitals and physicians to promote care based on objective, evidence-based criteria," said Douglas R. Woll, M.D., senior vice president and chief medical officer of Blue Care Network.
Blue Distinction Centers for Complex and Rare Cancers were developed in strategic collaboration with the National Comprehensive Cancer Network, a consortium of 21 of the top cancer centers in the country that sets guidelines for cancer care. The U-M Comprehensive Cancer Center is a founding member of the NCCN. While not formally endorsing the designation, NCCN provided input and information.
The designation is based on rigorous, evidence-based selection criteria established in collaboration with leading clinicians, medical societies and professional organizations. The designation is focused primarily on multidisciplinary treatment planning and complex, major surgical treatments.
For information about treatments available at the U-M Comprehensive Cancer Center, visit our Cancers and Treatments web page or call the Cancer AnswerLine™ at 800-865-1125.
Written by Nicole Fawcett
|[an error occurred while processing this directive]|